Baar, 9 April 2025 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced that the shareholders approved all proposals put ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback